Value of tumor size as a prognostic factor in metastatic colorectal cancer patients after chemotherapy: a population-based study

被引：13
|
作者：
Yan, Qingying [1 ]
Zhang, Kai [1 ,2 ]
Guo, Kaibo [1 ]
Liu, Shan [3 ]
Wasan, Harpreet S. [4 ]
Jin, Huimin [1 ]
Yuan, Li [1 ]
Feng, Guan [1 ]
Shen, Fengfei [1 ]
Shen, Minhe [5 ]
Ma, Shenglin [6 ]
Ruan, Shanming [5 ,6 ]
机构：
[1] Zhejiang Chinese Med Univ, Clin Med Coll 1, Hangzhou 310053, Zhejiang, Peoples R China
[2] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY USA
[3] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Assessment Ctr, Hangzhou 310006, Zhejiang, Peoples R China
[4] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Dept Canc Med, London W12 0HS, England
[5] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China
[6] Zhejiang Chinese Med Univ, Clin Med Coll 4, Dept Oncol, Hangzhou 310053, Zhejiang, Peoples R China
来源：
FUTURE ONCOLOGY | 2019年 / 15卷 / 15期
基金：
中国国家自然科学基金; 中国博士后科学基金;
关键词：
chemotherapy; metastatic colorectal cancer; tumor size; SIDED COLON-CANCER; RISK-FACTORS; ONCOLOGICAL OUTCOMES; THERAPEUTIC APPROACH; CURATIVE RESECTION; SURVIVAL; RECURRENCE; STAGE; IMPACT; PROLIFERATION;
D O I：
10.2217/fon-2018-0785
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Aim: To evaluate the relationship between tumor size and survival in metastatic colorectal cancer (mCRC) patients who received chemotherapy. Materials & methods: SEER database was accessed for eligible patients. Multivariate Cox regression analysis was performed to compare the effect of tumor size on overall survival (OS) and CRC-specific survival (CCSS). Results: Tumor size >= 5cm was an independent risk factor for OS and CCSS in mCRC patients treated with chemotherapy. Tumor size <5cm did not show a survival advantage in patients whose primary tumor site was rectosigmoid junction, while tumor size >= 5cm was associated with poor OS and CCSS in left-and right-sided colorectal cancer. Conclusion: Tumor size >= 5cm was associated with poor prognosis after receiving chemotherapy treatment and a risk factor for survival of mCRC.
引用
收藏
页码：1745 / 1758
页数：14
相关论文
共 50 条
  • [21] Prognostic value of tumor size in stage II and III colorectal cancer in Tunisian population
    Nesrine, Mejri
    Manel, Dridi
    Soumaya, Labidi
    Houda, El Benna
    Nouha, Daoud
    Mehdi, Afrit
    Hamouda, Boussen
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [22] The prognostic value of sidedness of the primary tumor after local treatment for oligometastatic colorectal cancer: A Danish population based study
    Boysen, A.
    Spindler, K-L.
    Hoyer, M.
    Mortensen, F. V.
    Christensen, T. D.
    Ording, A. G.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [23] Hospital factors and metastatic surgery in colorectal cancer patients, a population-based cohort study
    Malin Ljunggren
    Caroline E. Weibull
    Emma Rosander
    Gabriella Palmer
    Bengt Glimelius
    Anna Martling
    Caroline Nordenvall
    [J]. BMC Cancer, 22
  • [24] Current use of MRI in patients with liver metastatic colorectal cancer: a population-based study
    Pech, Laurianne
    Cercueil, Jean-Pierre
    Jooste, Valerie
    Krause, Denis
    Facy, Olivier
    Bouvier, Anne-Marie
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (10) : 1126 - 1130
  • [25] KRAS Testing Status in Patients with Metastatic Colorectal Cancer - A Danish Population-Based Study
    Ording, Anne G.
    Froslev, Trine
    McCusker, Margaret
    Cheng, Elaine
    Wang, Lisa
    Ta, Julie
    Ehrenstein, Vera
    Sorensen, Henrik T.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 385 - 385
  • [26] Hospital factors and metastatic surgery in colorectal cancer patients, a population-based cohort study
    Ljunggren, Malin
    Weibull, Caroline E.
    Rosander, Emma
    Palmer, Gabriella
    Glimelius, Bengt
    Martling, Anna
    Nordenvall, Caroline
    [J]. BMC CANCER, 2022, 22 (01)
  • [27] Prognostic value of biomarkers in metastatic colorectal cancer patients
    Kataoka, Kozo
    Kanazawa, Akiyoshi
    Nakajima, Akio
    Yamaguchi, Ayane
    Arimoto, Akira
    [J]. JOURNAL OF SURGICAL RESEARCH, 2015, 194 (02) : 343 - 350
  • [28] Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab
    Neel I. Nissen
    Stephanie Kehlet
    Mogens K. Boisen
    Maria Liljefors
    Christina Jensen
    Astrid Z. Johansen
    Julia S. Johansen
    Janine T. Erler
    Morten Karsdal
    Joachim H. Mortensen
    Anette Høye
    Nicholas Willumsen
    [J]. Scientific Reports, 11
  • [29] Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab
    Nissen, Neel, I
    Kehlet, Stephanie
    Boisen, Mogens K.
    Liljefors, Maria
    Jensen, Christina
    Johansen, Astrid Z.
    Johansen, Julia S.
    Erler, Janine T.
    Karsdal, Morten
    Mortensen, Joachim H.
    Hoye, Anette
    Willumsen, Nicholas
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [30] Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab
    Nissen, N. I.
    Kehlet, S.
    Boisen, M. K.
    Liljefors, M.
    Jensen, C.
    Johansen, A. Z.
    Johansen, J. S.
    Erler, J.
    Karsdal, M. A.
    Mortensen, J.
    Hoye, A.
    Willumsen, N.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S290 - S290
12345